BETA: Please send your feedback!
Aclaris Therapeutics
ACRS:NAS
Pharmaceuticals: Other
$0
SMALL cap
$1.15
(0.00%)
-0.40%
since start of 2020
-0.29
About
Pharmaceuticals: Other
Founded 2012
Aclaris Therapeutics, Inc. is a clinical-stage specialty pharmaceutical company, which engages in identifying, developing and commercializing novel drugs to address unmet needs in dermatology. It also pursues the development of topical agents for the treatment and prevention of a number of medical and cosmetic indications. The company was founded by Neal S. Walker, Frank Ruffo, Kamil Ali-Jackson, Christopher V. Powala and Stuart D. Shanler in July 2012 and is headquartered in Malvern, PA.
website
Headquarters
Executives
| Name | Title | Gender |
| Neal S. Walker, PhD, MBA | President, Chief Executive Officer & Director | Male |
| Michael Stephen Tung, MD, MBA | Vice President-Investor Relations | Male |
| Stephen A. Tullman | Chairman | Male |
| Kamil Ali-Jackson | Chief Legal Officer | Female |
| Frank Ruffo, CPA | Chief Financial Officer | Male |
| Christopher V. Powala | Chief Operating Officer | Male |
| Stuart D. Shanler, MD | Chief Scientific Officer | Male |
Mindful Investing Summary
Aclaris Therapeutics - Competitors and Related Companies
How Aclaris Therapeutics stacks up to its peers in the Pharmaceuticals: Other industry or with competing business segments.
Aclaris Therapeutics
ACRS:NAS
Pharmaceuticals: Other
$0
SMALL cap
$1.15
(0.00%)
-0.40%
since start of 2020
-0.29
Omeros
OMER:NAS
Biotechnology
$737.19mm
SMALL cap
$13.60
(0.12%)
-0.04%
since start of 2020
-7.99
Onconova Therapeutics
ONTX:NAS
Biotechnology
$52.52mm
MICRO cap
$0.31
(0.02%)
-0.22%
since start of 2020
-0.12
Ophthotech
OPHT:NAS
Biotechnology
$0
MICRO cap
$1.44
(0.00%)
0.13%
since start of 2020
—
Ono Pharmaceutical
4528-JP:TKS
Pharmaceuticals: Other
—
LARGE cap
(—)
—
since start of 2020
—